论文部分内容阅读
目的 :分析热毒宁治疗急性上呼吸道感染(AURI)伴发热的治疗效果。方法 :选取我院在2014年1月至2016年1月收治的140例确诊为急性上呼吸道感染(AURI)的病人。采用热毒宁治疗的79例患儿为研究组,同期用利巴韦林治疗的61例患儿为对照组。对比两组患儿的症状,体征,退热时间的改善情况。结果 :研究组46例在6小时内退热,33例12小时内退热。对照组22例在6小时退热16例在24小时退热.研究组患儿退热时间明显短于对照组,结论 :采用热毒宁治疗急性上呼吸道感染(AURI)的患儿可在短时间内退热,改善临床症状,治疗效果满意。值得临床推广。
Objective: To analyze the therapeutic effect of Renduining on acute upper respiratory tract infection (AURI) with fever. Methods: One hundred and forty patients diagnosed as acute upper respiratory tract infection (AURI) in our hospital from January 2014 to January 2016 were selected. A total of 79 children treated with Rendoxin were included in the study group. 61 children treated with ribavirin during the same period were selected as the control group. The two groups of children with symptoms, signs, improvement of antipyretic time. Results: In the study group, 46 patients regressed within 6 hours and 33 patients regressed within 12 hours. In the control group, 22 cases were cured at 6 hours and 16 cases were relieved at 24 hours.The antipyretic time in the study group was significantly shorter than that in the control group.Conclusion: The treatment of AURI in the treatment group can be short Time fever, improve clinical symptoms, the treatment effect is satisfactory. Worth clinical promotion.